The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Multidrug-Resistant Bacteria in the Community
Open accessAbstract
Multidrug resistant (MDR) bacteria are one of the most important current threats to public health. Typically, MDR bacteria are associated with nosocomial infections. However, some MDR bacteria have become quite prevalent causes of community-acquired infections. The spread of MDR bacteria into the community is a crucial development, and is associated with increased morbidity, mortality, healthcare costs and antibiotic use. Factors associated with community dissemination of MDR bacteria overlap but are distinct from those associated with nosocomial spread. Community-associated (CA) MDR bacteria have an antibiotic resistance phenotype that is stable in the absence of antibiotic pressure of the type normally observed in hospitals or nursing homes. An exception to this rule may be those CA-MDR bacteria, of which the prevalence is driven by the presence of antibiotics in the food chain. Additionally, the colonization of otherwise healthy hosts is a common characteristic of CA-MDR bacteria. However, subtle immune deficiencies may still be present in the subjects colonized with specific CA-MDR bacteria. Methicillin-resistant S. aureus (MRSA) is the most prevalent of CA-MDR bacteria. CA-MRSA also has the greatest impact on morbidity and mortality. The main threat on the horizon is represented by Enterobacteriaceae. The production of extended spectrum β-lactamases in Enterobacteriaceae encountered in the community is becoming increasingly prevalent. Of great concern is the potential for the acquisition of carbapenemase genes in CA-Enterobacteriaceae. Prevention of further community spread of MDR bacteria is of the utmost importance, and will require a multi-disciplinary approach involving all stakeholders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Friedman, N. D., Kaye, K. S., Stout, J. E., McGarry, S. A., Trivette, S. L., Briggs, J. P., Lamm, W., Clark, C., MacFarquhar, J., Walton, A. L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-10-200211190-00007 · Cited by 1,668
The shared antibiotic resistome of soil bacteria and human pathogens
Forsberg, K. J., Reyes, A., Wang, B., Selleck, E. M., Sommer, M. O. A., & Dantas, G. (2012) · Science · doi:10.1126/science.1220761 · Cited by 1,650
Yigit, H., Queenan, A. M., Anderson, G. J., Domenech-Sanchez, A., Biddle, J. W., Steward, C. D., Alberti, S., Bush, K., & Tenover, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1151-1161.2001 · Cited by 1,639
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Nordmann, P., Cuzon, G., & Naas, T. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70054-4 · Cited by 1,579
Community-associated meticillin-resistant Staphylococcus aureus
DeLeo, F. R., Otto, M., Kreiswirth, B. N., & Chambers, H. F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61999-1 · Cited by 1,506
Walsh, T. R., Weeks, J., Livermore, D. M., & Toleman, M. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70059-7 · Cited by 1,250
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01456.x · Cited by 1,051
Health Care Costs and Mortality Associated with Nosocomial Diarrhea Due to Clostridium difficile
Kyne, L., Hamel, M. B., Polavaram, R., & Kelly, C. P. (2002) · Clinical Infectious Diseases · doi:10.1086/338260 · Cited by 904
Vancomycin-Resistant Enterococcal Infections
Murray, B. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421007 · Cited by 890
The changing epidemiology of resistance
Hawkey, P. M., & Jones, A. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp256 · Cited by 773
Munoz-Price, L. S., & Weinstein, R. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmra070741 · Cited by 772
Combating Antimicrobial Resistance: Policy Recommendations to Save Lives
Infectious Diseases Society of America (IDSA) (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir153 · Cited by 733
Community-Acquired Klebsiella pneumoniae Bacteremia: Global Differences in Clinical Patterns
Ko, W.-C., Paterson, D. L., Sagnimeni, A. J., Hansen, D. S., Von Gottberg, A., Mohapatra, S., Casellas, J. M., Goossens, H., Mulazimoglu, L., Trenholme, G., et al. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0802.010025 · Cited by 566
Self-citationGlobal dissemination of a multidrug resistant Escherichia coli clone
Petty, N. K., Ben Zakour, N. L., Stanton-Cook, M., Skippington, E., Totsika, M., Forde, B. M., Phan, M.-D., Gomes Moriel, D., Peters, K. M., Davies, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322678111 · Cited by 558
Self-citationSafdar, N., & Maki, D. G. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-11-200206040-00013 · Cited by 556
Hirsch, E. B., & Tam, V. H. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq108 · Cited by 477
Epstein, L., Hunter, J. C., Arwady, M. A., Tsai, V., Stein, L., Gribogiannis, M., Frias, M., Guh, A. Y., Laufer, A. S., Black, S., et al. (2014) · JAMA · doi:10.1001/jama.2014.12720 · Cited by 400
Rodriguez-Bano, J., Navarro, M. D., Retamar, P., Picon, E., Pascual, A., & the Extended-Spectrum Beta-Lactamases-Red Espanola de Investigacion en Patologia Infecciosa/Grupo de Estudio de Infeccion Hospitalaria Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir790 · Cited by 363
Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes
van Duin, D., Kaye, K. S., Neuner, E. A., & Bonomo, R. A. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.11.009 · Cited by 352
Self-citationPaterson, D. L. (2006) · Clinical Infectious Diseases · doi:10.1086/504476 · Cited by 344
Self-citationTamma, P. D., Han, J. H., Rock, C., Harris, A. D., Lautenbach, E., Hsu, A. J., Avdic, E., & Cosgrove, S. E. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ003 · Cited by 314
Livestock-associated methicillin-resistant Staphylococcus aureus in animals and humans
Graveland, H., Duim, B., van Duijkeren, E., Heederik, D., & Wagenaar, J. A. (2011) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2011.09.004 · Cited by 308
Li, W., Sun, G., Yu, Y., Li, N., Chen, M., Jin, R., Jiao, Y., & Wu, H. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit675 · Cited by 304
Klare, I., BADSTÜBNER, D., Konstabel, C., BÖHME, G., Claus, H., & Witte, W. (1999) · Microbial Drug Resistance · doi:10.1089/mdr.1999.5.45 · Cited by 304
Doi, Y., Park, Y. S., Rivera, J. I., Adams-Haduch, J. M., Hingwe, A., Sordillo, E. M., Lewis, J. S., Howard, W. J., Johnson, L. E., Polsky, B., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis942 · Cited by 303
Self-citationCarbapenem-Resistant Enterobacteriaceae: A Potential Threat
(2008) · JAMA · doi:10.1001/jama.2008.896 · Cited by 298
SARAVOLATZ, L. D., POHLOD, D. J., & ARKING, L. M. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-325 · Cited by 290
Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States
Coque, T. M., Tomayko, J. F., Ricke, S. C., Okhyusen, P. C., & Murray, B. E. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2605 · Cited by 279
The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study
Ena, J. (1993) · JAMA · doi:10.1001/jama.269.5.598 · Cited by 203
Vardakas, K. Z., Rafailidis, P. I., Konstantelias, A. A., & Falagas, M. E. (2013) · Journal of Infection · doi:10.1016/j.jinf.2012.10.028 · Cited by 202
Chen, A. F., Wessel, C. B., & Rao, N. (2013) · Clinical Orthopaedics & Related Research · doi:10.1007/s11999-013-2875-0 · Cited by 196
Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways
Hassett, D. J., Sutton, M. D., Schurr, M. J., Herr, A. B., Caldwell, C. C., & Matu, J. O. (2009) · Trends in Microbiology · doi:10.1016/j.tim.2008.12.003 · Cited by 196
Carbapenem-resistant Enterobacteriaceae: A menace to our most vulnerable patients
Perez, F., & Van Duin, D. (2013) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.80a.12182 · Cited by 184
Self-citationCoates, T., Bax, R., & Coates, A. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp159 · Cited by 181
Community-acquired Acinetobacter infections
Falagas, M. E., Karveli, E. A., Kelesidis, I., & Kelesidis, T. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0365-6 · Cited by 177
Morin, C. A., & Hadler, J. L. (2001) · The Journal of Infectious Diseases · doi:10.1086/323459 · Cited by 172
Antimicrobial Stewardship Programs in Inpatient Hospital Settings: A Systematic Review
Wagner, B. L., FILICE, G. A., Drekonja, D. M., Greer, N. L., MacDonald, R. H., Rutks, I. R., Butler, M. E., & Wilt, T. J. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/599172 · Cited by 170
Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections
Neuner, E. A., Yeh, J.-Y., Hall, G. S., Sekeres, J., Endimiani, A., Bonomo, R. A., Shrestha, N. K., Fraser, T. G., & van Duin, D. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.10.013 · Cited by 166
Self-citationThurlow, L. R., Joshi, G. S., & Richardson, A. R. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00937.x · Cited by 166
Kaye, K. S., Harris, A. D., Samore, M. H., & Carmeli, Y. (2005) · Infection Control and Hospital Epidemiology · doi:10.1086/502550 · Cited by 163
Eveillard, M., Kempf, M., Belmonte, O., Pailhoriès, H., & Joly-Guillou, M.-L. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.03.021 · Cited by 161
Ruimy, R., Angebault, C., Djossou, F., Dupont, C., Epelboin, L., Jarraud, S., Armand-Lefèvre, L., Bes, M., Lixandru, B. E., Bertine, M., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/655901 · Cited by 145
Bates, J. L. (1997) · Journal of Hospital Infection · doi:10.1016/s0195-6701(97)90179-1 · Cited by 141
Bloodstream Infections in Community Hospitals in the 21st Century: A Multicenter Cohort Study
Anderson, D. J., Moehring, R. W., Sloane, R. J., Schmader, K. E., Weber, D. J., Fowler, V. G., Smathers, E. C., & Sexton, D. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091713 · Cited by 134
Rodríguez‐Baño, J., López-Prieto, M. D., Portillo, M. M., Retamar, P., Natera, C., Nuño, E., Herrero, M., del Arco, A., Muñoz, Á., Téllez, F., et al. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03089.x · Cited by 132
Peirano, G., Schreckenberger, P. C., & Pitout, J. D. D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01763-10 · Cited by 131
Combating Antimicrobial Resistance: Policy Recommendations to Save Lives
(2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir154 · Cited by 125
Marathe, N. P., Regina, V. R., Walujkar, S. A., Charan, S. S., Moore, E. R. B., Larsson, D. G. J., & Shouche, Y. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077310 · Cited by 122
Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci
Foucault, M.-L., Depardieu, F., Courvalin, P. M., & Grillot‐Courvalin, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006855107 · Cited by 121
Alam, T., Read, T. D., Petit, R. A., Boyle‐Vavra, S., Miller, L. G., Eells, S. J., Daum, R. S., & David, M. Z. (2015) · mBio · doi:10.1128/mbio.00054-15 · Cited by 121
Bhargava, A., Hayakawa, K., Silverman, E., Haider, S., Alluri, K., Datla, S., Diviti, S., Kuchipudi, V., Muppavarapu, K. S., Lephart, P., et al. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/675614 · Cited by 103
Community-acquired methicillin-resistant Staphylococcus aureus: what do we need to know?
Witte, W. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03097.x · Cited by 87
Queenan, A. M., Pillar, C. M., Deane, J., Sahm, D. F., Lynch, A. S., Flamm, R. K., Peterson, J., & Davies, T. A. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.04.002 · Cited by 84
Leistner, R., Meyer, E., Gastmeier, P., Pfeifer, Y., Eller, C., Dem, P., & Schwab, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074323 · Cited by 82
Association between Vancomycin-Resistant Enterococci Bacteremia and Ceftriaxone Usage
McKinnell, J. A., Kunz, D. F., Chamot, E., Patel, M., Shirley, R. M., Moser, S. A., Baddley, J. W., Pappas, P. G., & Miller, L. G. (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/666331 · Cited by 81
A 16-Year Prospective Study of Community-Onset Bacteremic Acinetobacter Pneumonia
Davis, J. S., McMillan, M., Swaminathan, A. D., Kelly, J. A., Piera, K., Baird, R., Currie, B. J., & Anstey, N. M. (2014) · CHEST Journal · doi:10.1378/chest.13-3065 · Cited by 72
Pannaraj, P. S., Bard, J. D., Cerini, C., & Weissman, S. J. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000471 · Cited by 69
Infection Control in Cystic Fibrosis: Cohorting, Cross-Contamination, and the Respiratory Therapist
O'Malley, C. A. (2009) · Respiratory Care · doi:10.4187/aarc0446 · Cited by 66
Hattemer, A., Hauser, A. R., Diaz, M. H., Scheetz, M. H., Shah, N. S., Allen, J. P., Porhomayon, J., & El-Solh, A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02467-12 · Cited by 66
Banerjee, R., Strahilevitz, J., Johnson, J. R., Nagwekar, P. P., Schora, D. M., Shevrin, I., Du, H., Peterson, L. R., & Robicsek, A. A. (2013) · Infection Control and Hospital Epidemiology · doi:10.1086/671725 · Cited by 63
Impact of Gram-positive resistance on outcome of nosocomial pneumonia
Bodí, M. A., Ardanuy, C., & Rello, J. (2001) · Critical Care Medicine · doi:10.1097/00003246-200104001-00005 · Cited by 60
Pheromone killing of multidrug-resistant Enterococcus faecalis V583 by native commensal strains
Gilmore, M. S., Rauch, M., Ramsey, M. M., Himes, P., Varahan, S., Manson, J. M., Lebreton, F., & Hancock, L. E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500553112 · Cited by 59
Johnsen, P. J., Townsend, J. P., Bøhn, T., Simonsen, G. S., Sundsfjord, A., & Nielsen, K. M. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq512 · Cited by 56
Prevalence and risk factors for antibiotic-resistant community-associated bloodstream infections
Wolfe, C. M., Cohen, B., & Larson, E. (2014) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2014.01.001 · Cited by 36
Vinski, J., Bertin, M. L., Sun, Z., Gordon, S. M., Bokar, D., Merlino, J. I., & Fraser, T. G. (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/665314 · Cited by 35
Bruinsma, N., Stobberingh, E. E., de Smet, P., & van den Bogaard, A. E. J. M. (2003) · Infection · doi:10.1007/s15010-002-3035-8 · Cited by 32
Community dissemination of vancomycin-resistant Enterococcus faecium
D’Agata, E. M. C., Jirjis, J. N., Gouldin, C., & Tang, Y. (2001) · American Journal of Infection Control · doi:10.1067/mic.2001.117448 · Cited by 25
Poole, T. L., Hume, M. E., Campbell, L., Scott, H. M., Alali, W. Q., & Harvey, R. B. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4382-4385.2005 · Cited by 23
Omotola, A. M., Li, Y., Martin, E. T., Alshabani, K., Yadav, D., Sarkar, M., Thapa, S. D., Kumar, V., Mahabashya, A., Ahmad, S. S., et al. (2013) · American Journal of Infection Control · doi:10.1016/j.ajic.2013.05.025 · Cited by 17
Cited by
The global epidemiology of carbapenemase-producing Enterobacteriaceae
van Duin, D., & Doi, Y. (2017) · Virulence · doi:10.1080/21505594.2016.1222343 · Cited by 1,004
Self-citationGan, B. H., Gaynord, J., Rowe, S. M., Deingruber, T., & Spring, D. R. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00729c · Cited by 511
Plant Extracts Mediated Metal-Based Nanoparticles: Synthesis and Biological Applications
Adeyemi, J. O., Oriola, A. O., Onwudiwe, D. C., & Oyedeji, A. O. (2022) · Biomolecules · doi:10.3390/biom12050627 · Cited by 367
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
Jean, S.-S., Harnod, D., & Hsueh, P.-R. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.823684 · Cited by 366
Global geographic trends in antimicrobial resistance: the role of international travel
Frost, I., Van Boeckel, T. P., Pires, J., Craig, J., & Laxminarayan, R. (2019) · Journal of Travel Medicine · doi:10.1093/jtm/taz036 · Cited by 338
Metadata
- Authors
- van Duin, D., & Paterson, D. L.
- Venue
- Infectious Disease Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 30
- Issue
- 2
- Pages
- 377-390
- ISSN
- 0891-5520 (ISSN-L)
- OpenAlex
- W2405903593
- Cited by
- 584
- References
- 72
- FWCI
- 12.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.